Found: 44
Select item for more details and to access through your institution.
Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still's Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 910, doi. 10.3390/jcm10050910
- By:
- Publication type:
- Article
Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3968, doi. 10.3390/jcm9123968
- By:
- Publication type:
- Article
Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients.
- Published in:
- Journal of Immunology Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/487230
- By:
- Publication type:
- Article
Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-33718-7
- By:
- Publication type:
- Article
Susceptibility and Resistance of Field Populations of Anopheles sinensis (Diptera: Culicidae) Collected from Paju to 13 Insecticides.
- Published in:
- Osong Public Health & Research Perspectives, 2013, v. 4, n. 2, p. 76, doi. 10.1016/j.phrp.2013.02.001
- By:
- Publication type:
- Article
Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis.
- Published in:
- Scientific Reports, 2016, p. 27563, doi. 10.1038/srep27563
- By:
- Publication type:
- Article
Impact of Infliximab Biosimilar CT-P13 Dose and Infusion Interval on Real-World Drug Survival and Effectiveness in Patients with Ankylosing Spondylitis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 19, p. 4568, doi. 10.3390/jcm10194568
- By:
- Publication type:
- Article
Safety of baricitinib in East Asian patients with moderate‐to‐severe active rheumatoid arthritis: An integrated analysis from clinical trials.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 1, p. 65, doi. 10.1111/1756-185X.13748
- By:
- Publication type:
- Article
Prevalence of co‐morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross‐sectional study (COMORA).
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 7, p. 1414, doi. 10.1111/1756-185X.13013
- By:
- Publication type:
- Article
Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 5, p. 1031, doi. 10.1111/1756-185X.13274
- By:
- Publication type:
- Article
The importance of assessment and management of morning stiffness in Asian patients with rheumatoid arthritis: Recommendations from an expert panel.
- Published in:
- International Journal of Rheumatic Diseases, 2016, v. 19, n. 1, p. 30, doi. 10.1111/1756-185X.12755
- By:
- Publication type:
- Article
Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 11, p. 3409, doi. 10.1007/s10067-019-04782-0
- By:
- Publication type:
- Article
Treating rheumatoid arthritis to target: recommendations assessment questionnaire in Korea.
- Published in:
- Clinical Rheumatology, 2013, v. 32, n. 12, p. 1791, doi. 10.1007/s10067-013-2365-5
- By:
- Publication type:
- Article
Induction of Remission with Intravenous Immunoglobulin and Cyclophosphamide in Steroid-Resistant Evans’ Syndrome Associated with Dermatomyositis.
- Published in:
- Clinical Rheumatology, 2001, v. 20, n. 1, p. 63, doi. 10.1007/s100670170107
- By:
- Publication type:
- Article
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221314
- By:
- Publication type:
- Article
Transcriptomic network analysis reveals key drivers of response to anti-TNF biologics in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 5, p. 1422, doi. 10.1093/rheumatology/kead403
- By:
- Publication type:
- Article
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2838, doi. 10.1093/rheumatology/keac689
- By:
- Publication type:
- Article
Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity.
- Published in:
- Rheumatology, 2011, v. 50, n. 6, p. 1054, doi. 10.1093/rheumatology/keq457
- By:
- Publication type:
- Article
A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 541, doi. 10.1007/s40261-020-00907-5
- By:
- Publication type:
- Article
Nontuberculous mycobacterial myositis in dermatomyositis with long-term use of immunosuppressant: a case report.
- Published in:
- Skeletal Radiology, 2024, v. 53, n. 10, p. 2289, doi. 10.1007/s00256-023-04444-y
- By:
- Publication type:
- Article
Erratum to "Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients".
- Published in:
- 2017
- By:
- Publication type:
- corrected article
Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0150283
- By:
- Publication type:
- Article
Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective.
- Published in:
- Respirology, 2013, v. 18, n. 5, p. 765, doi. 10.1111/resp.12106
- By:
- Publication type:
- Article
Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03362-1
- By:
- Publication type:
- Article
Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03024-8
- By:
- Publication type:
- Article
Factors associated with selection of targeted therapy in patients with rheumatoid arthritis.
- Published in:
- PLoS ONE, 2023, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0280234
- By:
- Publication type:
- Article
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
- Published in:
- Rheumatology International, 2017, v. 37, n. 10, p. 1735, doi. 10.1007/s00296-017-3781-7
- By:
- Publication type:
- Article
Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
- Published in:
- Rheumatology International, 2017, v. 37, n. 6, p. 1007, doi. 10.1007/s00296-017-3663-z
- By:
- Publication type:
- Article
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 4, p. 572, doi. 10.3109/14397595.2013.860695
- By:
- Publication type:
- Article
Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 3, p. 503, doi. 10.3109/s10165-012-0673-2
- By:
- Publication type:
- Article
Comparative Effectiveness of Azathioprine Versus Cyclosporine as an Initial Treatment for Idiopathic Inflammatory Myopathies: A Population-Based Observational Study.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 1, p. 139, doi. 10.1007/s40744-021-00392-y
- By:
- Publication type:
- Article
Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1983-y
- By:
- Publication type:
- Article
Prevalence and predictors for sustained remission in rheumatoid arthritis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0214981
- By:
- Publication type:
- Article
Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study.
- Published in:
- Rheumatology International, 2016, v. 36, n. 9, p. 1205, doi. 10.1007/s00296-016-3453-z
- By:
- Publication type:
- Article
Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases.
- Published in:
- Rheumatology International, 2014, v. 34, n. 12, p. 1711, doi. 10.1007/s00296-014-3033-z
- By:
- Publication type:
- Article
Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis.
- Published in:
- Rheumatology International, 2013, v. 33, n. 8, p. 2159, doi. 10.1007/s00296-012-2370-z
- By:
- Publication type:
- Article
The single nucleotide polymorphisms of matrix metalloproteinase-1 in patients with systemic sclerosis.
- Published in:
- 2008
- By:
- Publication type:
- Letter
High expression of CD40 on skin fibroblasts from patients with systemic sclerosis.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 9, p. 1566, doi. 10.1002/art.42516
- By:
- Publication type:
- Article
Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56987-2
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial.
- Published in:
- BioDrugs, 2019, v. 33, n. 1, p. 79, doi. 10.1007/s40259-018-00331-4
- By:
- Publication type:
- Article
Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02487-x
- By:
- Publication type:
- Article